In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
  • Select congresses

    Select Select congresses(s)

  • Year

    Select Year(s)

  • Resource type

    Select Resource type(s)

  • Topic

    Select Topic(s)

Filters (0)
  • Select congresses
  • sub-topic
  • Year
  • Resource type
  • Topic
  • Select congresses
  • sub-topic
  • Year
  • Resource type
  • Topic

1468 results for your search

. always combined endocardial-epicardial first

Congress : EHRA 2019

  • Session : Ventricular tachycardia ablation in ischaemic cardiomyopathy - How early and how invasive?
  • Speaker : L Di Biase (New York,US)

. only after drug failure

Congress : EHRA 2019

  • Session : Ventricular tachycardia ablation in ischaemic cardiomyopathy - How early and how invasive?
  • Speaker : K Soejima (Tokyo,JP)

... before the second episode - Don't wait for recurrences!

Congress : EHRA 2019

  • Session : Ventricular tachycardia ablation in ischaemic cardiomyopathy - How early and how invasive?
  • Speaker : K Kuck (Hamburg,DE)

...always endocardial first

Congress : EHRA 2019

  • Session : Ventricular tachycardia ablation in ischaemic cardiomyopathy - How early and how invasive?
  • Speaker : K Zeppenfeld (Leiden,NL)

Three reasons why you should become a member

Become a member now
  • 1Access your congress resources all year-round on the New ESC 365
  • 2Get a discount on your next congress registration
  • 3Continue your professional development with free access to educational tools
Become a member now

Our sponsors

ESC 365 is supported by Bayer, Boehringer Ingelheim, Bristol-Myers Squibb and Pfizer Alliance, and Novartis Pharma AG. The sponsors were not involved in the development of this platform and had no influence on its content.

logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are